We identified the novel association of SNRPD1 with cell cycle progression in breast cancers, and therefore proposed SNRPD1 as a novel target for breast cancer control through halting cell cycle progression at the G0/G1 phase. This evidence concerns the gene SNRPD1 and breast carcinoma.